Securus Technologies Company is considered as a prominent company serving the inmate industry through technology solutions. For you to develop incoming messaging activities, you must be determined to accept your income accessibilities in a way that has no parallel solutions. Securus Technologies Company is a company that acts as the reception of straightforward deals. If there is any remaining company dealing without corruption in the correctional space, then Securus Technologies Company will top that list. Securus Technologies Company has constantly engaged in hard work to develop their sophisticated technology solutions to companies and other individuals. Securus Technologies Company also measures their performance ratio through the satisfactory rate achieved in the industry.
Securus Technologies Company has also worked with the United States Better Business Bureau to get the highest form of accreditation. Securus Technologies Company has also been issued an A+ rating from the Better Business Bureau. The Better business bureau is a Dallas-based company that offers working solutions to other companies in a way that is not paralleled in the industry. If there are many people engaged in developing fast income, then Securus Technologies Company is one of the top income generating companies in the correctional space. Securus Technologies Company has also received an A+ rating and accreditation by the better business company.
Securus Technologies Company is a company that leads in the provision of technology solutions to the correctional space to enhance criminal and civil justice. For the company, they are happy to become part of the solutions to increase investigation, public safety, monitoring, and corrections in the inmate industry. Securus Technologies Company has announced the reception of accreditation from the Better Business Bureau. Danny De Hoyos is the Senior President and CEO of Securus Technologies Company. The accreditation comes as a voluntary action. If a company wants to be accredited, it must satisfy the set criteria for accreditation by the Better Business Bureau.
A walk through Arthur Becker’s real estate office in Tribeca would yield to you some interesting information. Becker is a big name and face in the New York real estate world but his office paints a slightly different picture. One half of his artist is dedicated to all things real estate while the other half is focused on his artwork. The art studio is filled with paintings, sculptures, and works in progress. Becker is a wonderful example of a man with multiple passions who has managed to balance them in his business life.
Right now Arthur Becker’s attention seems primarily focused on his work at 465 Washington Street in New York. His goal for this building is to develop a multi-unit condo that blends his love of art and fashion with his take on what luxury and high end apartments are lacking. The condo development is valued at $53 million and we expect to see the solo project come to fruition sooner than later. For years Becker has been mostly playing the role of real estate investor behind the scenes, seemingly not interested in having his name on the building. Now it appears that the times have changed and Becker wants his work known. We’re eager to see what happens with the building as work continues.
In an article on NY Daily News, in order to get his building going at 465 Washington Street Becker had to make some moves. Back in August Becker had to cut a deal with adjacent townhouses on Sullivan Street in order to complete his building the way he had planned it. These townhouses were acquired in exchange for a stake in the condo after it gets built. This is the kind of dealmaker that has made Becker such a force int he real estate world. Becker has also been the money man behind works from Michael Stern and Kevin Maloney.
Arthur Becker got his start back in the early 2000’s when he struck a goldmine as a stockbroker working with various tech companies. Becker translated that first fortune into his current success in the realm of real estate, largely focusing on New York.
Click here: https://angel.co/arthur-becker-nyc
JeanMarie Guenot graduated from Wharton School of business with an MBA. She went on to receive a Ph.D. from the University of California, San Francisco. She is a business executive who has over 20 years of experience in the biotechnology and pharmaceutical industry. JeanMarie Guenot currently is the CEO and President of Amphivena Therapeutics, Inc. Amphivena technologies on guenotllc.com. The company works with developing bifunctional antibody therapies for hematologic disorders. Their work with immunotherapy and leukemia has shown positive results.
The sphere of blood diseases has a high need for development and new technology.
JeanMarie Guenot has worked with companies in all stages of development in the public and the private sector. Before her current role, Guenot worked with SKS Ocular which specialized in ophthalmics. She founded, ran, and built that company.
Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies
Her prior experience in biotechnology and pharmacy includes working with PDL BioPharma, where she was Vice President of Corporate & Business Development. There they developed treatments for Phase 2 cancer and autoimmunology disease drug candidates. In 2005, JeanMarie Guenot received the Innovative Bio-Partnering Award from BioBusiness. Her work in oncology spans years. She began her career as a preclinical scientist at R&D at Hoffmann-La Roche developing medicines for cancer, autoimmune diseases, and inflammation.
Learn more about Jeanmarie Guenot: http://www.businesswire.com/news/home/20170111005414/en/Maverick-Therapeutics-Takeda-Announce-Five-year-Collaboration-Advance